– a generally known phenomenon? This is probably because it is being referenced more and more in policy (and funding related) documents and this is because multimorbidity is identified as a cause of increased health care costs.
A few decades ago, chronic diseases began to assume importance as they became relatively more common when compared to acute illnesses and as infectious diseases have become more treatable. Co-morbidities then began to be mentioned in specialist clinics where it was noted that, for instance, patients with COPD might also have cardiac or peripheral vascular disease – and that these co-morbidities and their treatments might impact on the disease under care.
This was a rather specialist view. In the Geriatric
In
The American Geriatric Society has produced a handy Pocketcard summary of their guidelines.
In the UK, Multimorbidity guidelines have been produced
Minimally Disruptive Medicine: Is healthcare careful? Is it kind?
MedEdPurls has three posts on Teaching Multimorbidity:
http://mededpurls.com/blog/index.php/2016/10/31/teaching-multimorbidity-part-one/
http://mededpurls.com/blog/index.php/2016/11/05/teaching-multimorbidity-part-two/
http://mededpurls.com/blog/index.php/2016/11/13/teaching-multimorbidity-part-three/
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreCrohn’s disease (CD) is a chronic inflammatory bowel disease affecting any part of the GI tract. It has genetic and environmental triggers and presents with symptoms like abdominal pain, diarrhoea, and weight loss. Diagnosis involves endoscopy and imaging. Management includes corticosteroids, biologics, immunomodulators, lifestyle changes, and psychological support. This FastTrack-CPD provides a clinical summary on the management of Crohn's disease with a quiz to apply your learning and receive CPD (RP and EA categories).
Australian Therapeutic Guidelines for the management of gout have recently been updated to reflect current evidence. Rheumatologist Dr Alana Bruce explains what prescribers and other HPs should know about these updates to ensure optimal care for their patients with gout.
Polycystic ovary syndrome (PCOS) affects 10–13% of women, with higher prevalence in certain ethnic groups. It is characterized by hyperandrogenism, menstrual irregularities, and polycystic ovarian morphology. PCOS increases the risk of type 2 diabetes, cardiovascular disease, and requires early diagnosis and personalized management to reduce long-term effects. This FastTrack-CPD provides a clinical summary on the management of PCOS with a quiz to apply your learning and receive CPD (RP and EA categories).